Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) Cbtrus statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015. Neuro Oncol 20:iv1–iv86

Article  PubMed  PubMed Central  Google Scholar 

Talbäck M, Stenbeck M, Rosén M (2004) Up-to-date long-term survival of cancer patients: an evaluation of period analysis on Swedish Cancer Registry Data. Eur J Cancer 40(9):1361–1372

Article  PubMed  Google Scholar 

Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99(3):307–314

Article  PubMed  PubMed Central  Google Scholar 

Champeaux C, Houston D, Dunn L, Resche-Rigon M (2019) Intracranial who grade I meningioma: a competing risk analysis of progression and disease-specific survival. Acta Neurochir (Wien) 161(12):2541–2549

Article  Google Scholar 

Sturgeon KM, Deng L, Bluethmann SM, Zhou S, Trifiletti DM, Jiang C, Kelly SP, Zaorsky NG (2019) A population-based study of cardiovascular disease mortality risk in us cancer patients. Eur Heart J 40(48):3889–3897

Article  PubMed  PubMed Central  Google Scholar 

Troeschel AN, Liu Y, Collin LJ, Bradshaw PT, Ward KC, Gogineni K, McCullough LE (2019) Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer. Int J Epidemiol 48(6):1897–1905

Article  PubMed  Google Scholar 

Felix AS, Bower JK, Pfeiffer RM, Raman SV, Cohn DE, Sherman ME (2017) High cardiovascular disease mortality after endometrial cancer diagnosis: results from the Surveillance, Epidemiology, and End Results (SEER) database. Int J Cancer 140(3):555–564

Article  CAS  PubMed  Google Scholar 

Gaitanidis A, Spathakis M, Tsalikidis C, Alevizakos M, Tsaroucha A, Pitiakoudis M (2019) Risk factors for cardiovascular mortality in patients with colorectal cancer: a population-based study. Int J Clin Oncol 24(5):501–507

Article  PubMed  Google Scholar 

Kamel MG, El-Qushayri AE, Thach TQ, Huy NT (2018) Cardiovascular mortality trends in non-Hodgkin's lymphoma: a population-based cohort study. Expert Rev Anticancer Ther 18(1):91–100

Article  CAS  PubMed  Google Scholar 

Agarwal V, McCutcheon BA, Hughes JD, Carlson ML, Glasgow AE, Habermann EB, Nguyen QB, Link MJ, Van Gompel JJ (2017) Trends in management of intracranial meningiomas: analysis of 49,921 cases from modern cohort. World Neurosurg 106:145–151

Article  PubMed  Google Scholar 

Leães CG, Meurer RT, Coutinho LB, Ferreira NP, Pereira-Lima JF, da Costa Oliveira M (2010) Immunohistochemical expression of aromatase and estrogen, androgen and progesterone receptors in normal and neoplastic human meningeal cells. Neuropathology 30(1):44–49

Article  PubMed  Google Scholar 

Blankenstein MA, Verheijen FM, Jacobs JM, Donker TH, van Duijnhoven MW, Thijssen JH (2000) Occurrence, regulation, and significance of progesterone receptors in human meningioma. Steroids 65(10-11):795–800

Article  CAS  PubMed  Google Scholar 

Maxwell M, Galanopoulos T, Neville-Golden J, Antoniades HN (1993) Expression of androgen and progesterone receptors in primary human meningiomas. J Neurosurg 78(3):456–462

Article  CAS  PubMed  Google Scholar 

Korhonen K, Salminen T, Raitanen J, Auvinen A, Isola J, Haapasalo H (2006) Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. J Neurooncol 80(1):1–7

Article  CAS  PubMed  Google Scholar 

Hsu DW, Efird JT, Hedley-Whyte ET (1997) Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 86(1):113–120

Article  CAS  PubMed  Google Scholar 

Hua L, Zhu H, Li J, Tang H, Kuang D, Wang Y, Tang F, Chen X, Zhou L, Xie Q, Gong Y (2018) Prognostic value of estrogen receptor in who grade iii meningioma: a long-term follow-up study from a single institution. J Neurosurg 128(6):1698–1706

Article  PubMed  Google Scholar 

Guetta V, Cannon RO 3rd. (1996) Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. Circulation 93(10):1928–1937

Article  CAS  PubMed  Google Scholar 

Hanke H, Hanke S, Finking G, Muhic-Lohrer A, Mück AO, Schmahl FW, Haasis R, Hombach V (1996) Different effects of estrogen and progesterone on experimental atherosclerosis in female versus male rabbits. Quantification of cellular proliferation by bromodeoxyuridine. Circulation 94(2):175–181

Article  CAS  PubMed  Google Scholar 

Hamada H, Kim MK, Iwakura A, Ii M, Thorne T, Qin G, Asai J, Tsutsumi Y, Sekiguchi H, Silver M, Wecker A, Bord E, Zhu Y, Kishore R, Losordo DW (2006) Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation 114(21):2261–2270

Article  CAS  PubMed  Google Scholar 

Vahidinia Z, Karimian M, Joghataei MT (2020) Neurosteroids and their receptors in ischemic stroke: from molecular mechanisms to therapeutic opportunities. Pharmacol Res 160:105163

Article  CAS  PubMed  Google Scholar 

Abuamsha H, Kadri AN, Hernandez AV (2019) Cardiovascular mortality among patients with non-Hodgkin lymphoma: differences according to lymphoma subtype. Hematol Oncol 37(3):261–269

Article  CAS  PubMed  Google Scholar 

Zhao J, Su L, Zhong J (2020) Risk factors for cancer-specific mortality and cardiovascular mortality in patients with diffuse large B-cell lymphoma. Clin Lymphoma Myeloma Leuk 20(11):e858–ee63

Article  PubMed  Google Scholar 

Bhambhvani HP, Rodrigues AJ, Medress ZA, Hayden Gephart M (2020) Racial and socioeconomic correlates of treatment and survival among patients with meningioma: a population-based study. J Neurooncol 147(2):495–501

Article  PubMed  Google Scholar 

Zaher A, Abdelbari Mattar M, Zayed DH, Ellatif RA, Ashamallah SA (2013) Atypical meningioma: a study of prognostic factors. World Neurosurg 80(5):549–553

Article  PubMed  Google Scholar 

Garzon-Muvdi T, Yang W, Lim M, Brem H, Huang J (2017) Atypical and anaplastic meningioma: outcomes in a population based study. J Neurooncol 133(2):321–330

Article  CAS  PubMed  Google Scholar 

Reddy AK, Ryoo JS, Denyer S, McGuire LS, Mehta AI (2019) Determining the role of adjuvant radiotherapy in the management of meningioma: a surveillance, epidemiology, and end results analysis. Neurosurg Focus 46(6):E3

Article  PubMed  Google Scholar 

Li D, Jiang P, Xu S, Li C, Xi S, Zhang J, Chen Y, Jiang X, Zhang X, Sai K, Wang J, Mou Y, Ke C, Chen Z (2019) Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas. J Neurooncol 145(1):125–134

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou H, Bai HX, Chan L, Zhang PJ, Karakousis G, Huang R, Xiao B, Yang L (2019) Survival benefit of adjuvant radiotherapy in elderly patients with who grade iii meningioma. World Neurosurg 131:e303–ee11

Article  PubMed  Google Scholar 

Corniola MV, Lemée JM, Meling TR (2020) Resection of meningiomas in octogenarians: a comparison with a younger geriatric population. Neurosurg Focus 49(4):E18

Article  PubMed  Google Scholar 

Dudley RWR, Torok MR, Randall S, Béland B, Handler MH, Mulcahy-Levy JM, Liu AK, Hankinson TC (2018) Pediatric versus adult meningioma: comparison of epidemiology, treatments, and outcomes using the Surveillance, Epidemiology, and End Results database. J Neurooncol 137(3):621–629

Article  PubMed  Google Scholar 

Aizer AA, Bi WL, Kandola MS, Lee EQ, Nayak L, Rinne ML, Norden AD, Beroukhim R, Reardon DA, Wen PY, Al-Mefty O, Arvold ND, Dunn IF, Alexander BM (2015) Extent of resection and overall survival for patients with atypical and malignant meningioma. Cancer 121(24):4376–4381

Article  PubMed  Google Scholar 

Moser EC, Noordijk EM, van Leeuwen FE, le Cessie S, Baars JW, Thomas J, Carde P, Meerwaldt JH, van Glabbeke M, Kluin-Nelemans HC (2006) Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma. Blood 107(7):2912–2919

Article  CAS  PubMed  Google Scholar 

Ayyappan SR, Diamond A, Gupta V, Cooper B, Tomlinson BK, Malek E, Metheny L, Lazarus HM, Gerson SL, De Lima M, Caimi PF (2016) Cardiovascular toxicity after therapy for diffuse large B cell lymphoma occurs early and results in decreased overall survival. Blood 128(22):105–105

Article  Google Scholar 

Dresser L, Yuen CA, Wilmington A, Walker M, Vogel TJ, Merrell RT, Kamson DO (2020) Estrogen hormone replacement therapy in incidental intracranial meningioma: a growth-rate analysis. Sci Rep 10(1):17960

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karsy M, Hoang N, Barth T, Burt L, Dunson W, Gillespie DL, Jensen RL (2016) Combined hydroxyurea and verapamil in the clinical treatment of refractory meningioma: human and orthotopic xenograft studies. World Neurosurg 86:210–219

Article  PubMed  Google Scholar 

Ji Y, Rankin C, Grunberg S, Sherrod AE, Ahmadi J, Townsend JJ, Feun LG, Fredericks RK, Russell CA, Kabbinavar FF, Stelzer KJ, Schott A, Verschraegen C (2015) Double-blind phase III randomized trial of the antiprogestin agent mifepristone in the treatment of unresectable meningioma: Swog S9005. J Clin Oncol 33(34):4093–4098

Article  CAS  PubMed  PubMed Central